Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, presented data regarding its E. coli O157:H7 cattle vaccine at the XXV World Buiatrics Congress in Budapest, Hungary today.
Click here to see more...